{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:04:32Z","timestamp":1759010672180},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T00:00:00Z","timestamp":1410825600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0106393","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T17:51:10Z","timestamp":1410889870000},"page":"e106393","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["Combination Therapy with Antibiotics and Anthrax Immune Globulin Intravenous (AIGIV) Is Potentially More Effective than Antibiotics Alone in Rabbit Model of Inhalational Anthrax"],"prefix":"10.1371","volume":"9","author":[{"given":"Srinivas","family":"Kammanadiminti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi Kumar","family":"Patnaikuni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Comer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Meister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shantha","family":"Kodihalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,9,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.5694\/j.1326-5377.2002.tb04594.x","article-title":"Biological agents as weapons 2: Anthrax and plague","volume":"176","author":"M Whitby","year":"2002","journal-title":"Med J Aust"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1001\/jama.287.17.2236","article-title":"Anthrax As a Biological Weapon, 2002: updated recommendations for management","volume":"287","author":"TV Inglesby","year":"2002","journal-title":"J Am Med Assoc"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3201\/eid0810.020349","article-title":"Antimicrobial post exposure prophylaxis for anthrax: adverse events and adherence","volume":"8","author":"CW Shepard","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-Related Inhalational Anthrax: The First 10 Cases Reported in the United States","volume":"7","author":"JA Jernigan","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jama.287.7.863","article-title":"Fatal Inhalational Anthrax in a 94-Year-Old Connecticut Woman","volume":"287","author":"LA Barakat","year":"2002","journal-title":"J Amer Med Assoc"},{"key":"ref6","unstructured":"CFR Part 601 (Subpart H): Approval of biological products when human efficacy studies are not ethical or feasible."},{"key":"ref7","volume":"31(4)","unstructured":"ILAR News (1989); <volume>31(4)<\/volume>: : 5\u201320."},{"key":"ref8","first-page":"A66p","article-title":"National Academies Press: Washington, DC","year":"2011","journal-title":"Chapter 3 \u2013 Environment, Housing, and Management"},{"key":"ref9","first-page":"982","article-title":"The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation","volume":"122","author":"GM Zaucha","year":"1998","journal-title":"Arch Pathol Lab Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa0810603","article-title":"Raxibacumab for the treatment of inhalational anthrax","volume":"361","author":"TS Migone","year":"2009","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1128\/CVI.00292-12","article-title":"Characterization of a therapeutic model of inhalational anthrax using an increase in body temperature in New Zealand white rabbits as a trigger for treatment","volume":"19(9)","author":"JE Comer","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/infdis\/167.5.1239","article-title":"Postexposure prophylaxis against experimental inhalational anthrax","volume":"167","author":"AM Friedlander","year":"1993","journal-title":"J Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1017\/S0022172400039279","article-title":"Observations on penicillin prophylaxis of experimental inhalation anthrax in the monkey","volume":"60","author":"WS Gochenour Jr","year":"1962","journal-title":"J Hyg"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1017\/S0022172400044272","article-title":"Observations on the prophylaxis of experimental pulmonary anthrax in the monkey","volume":"54","author":"DW Henderson","year":"1956","journal-title":"J Hyg"},{"key":"ref15","first-page":"127","article-title":"Antibiotic prophylaxis for inhalational anthrax","volume":"87","author":"MN Jones","year":"1996","journal-title":"Salisbury Med Bull (Special Supplement)"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1128\/AAC.00090-06","article-title":"Pharmacokinetic considerations and efficacy of levofloxacin in an inhalational anthrax (post exposure) rhesus monkey model","volume":"50","author":"ML Kao","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1086\/596063","article-title":"A short course of antibiotic treatment is effective in preventing death from experimental inhalational anthrax after discontinuing antibiotics","volume":"199","author":"NJ Vietri","year":"2009","journal-title":"J Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1128\/AAC.01689-10","article-title":"Antibiotics cure anthrax in animal models","volume":"55","author":"S Weiss","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.1073\/pnas.0502159102","article-title":"Anthrax lethal factor inhibition","volume":"102","author":"WL Shoop","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","unstructured":"Raxibacumab Treatment of Inhalation Anthrax BLA 124359- Anti-Infectives Advisory Committee Meeting Briefing Document. Nov 2, 2012; Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/Anti-InfectiveDrugsAdvisoryCommittee\/UCM326185.pdf\" xlink:type=\"simple\">http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/Anti-InfectiveDrugsAdvisoryCommittee\/UCM326185.pdf<\/ext-link>. Accessed 2014 August 19."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/toxins5010120","article-title":"Bacillus anthracis protective antigen kinetics in inhalation spore-challenged untreated or levofloxacin\/raxibacumab-treated New Zealand white rabbits","volume":"5(1)","author":"A Corey","year":"2013","journal-title":"Toxins (Basel)"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.1128\/IAI.70.11.6231-6241.2002","article-title":"Postexposure prophylaxis against anthrax: evaluation of various treatment regimens in intranasally infected guinea pigs","volume":"70","author":"Z Altboum","year":"2002","journal-title":"Infect Immun"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"7813","DOI":"10.1073\/pnas.0602748103","article-title":"Short-course post exposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax","volume":"103","author":"NJ Vietri","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0928-8244(03)00302-X","article-title":"Treatment of anthrax infection with combination of ciprofloxacin and antibodies to protective antigen of Bacillus anthracis","volume":"40","author":"V Karginov","year":"2004","journal-title":"FEMS Immunol and Med Microbiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1128\/IAI.74.2.1016-1024.2006","article-title":"Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax","volume":"74","author":"JW Peterson","year":"2006","journal-title":"Infect Immun"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0106393","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T13:33:37Z","timestamp":1598276017000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0106393"}},"subtitle":[],"editor":[{"given":"Nicholas S.","family":"Duesbery","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,16]]},"references-count":25,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0106393","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,16]]}}}